Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) P/E Ratio

The latest P/E ratio for SRNGU is -2.28. That is below the Healthcare sector average of 25.9. Investors often review this figure alongside Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, SRNGU currently prints -2.28 for P/E ratio, while the sector average sits near 25.9. That is roughly 108.8% below the sector mean. Large gaps often invite a closer look at Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s growth, margins, and balance sheet.

A P/E ratio of -2.28 for Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) is not 'good' or 'bad' on its own. Compare it with the peer average (25.9) and with SRNGU's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting SRNGU's P/E ratio (-2.28), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s P/E ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.